Company / Named in our posts
Beijing Continent Pharmaceuticals Co., Ltd.
Follow Beijing Continent Pharmaceuticals Co., LtdA commercial-stage biopharmaceutical company focused on researching and developing new drugs and manufacturing and commercializing ETUARY (pirfenidone capsule) for idiopathic pulmonary fibrosis and other pharmaceutical products.[1]
01Deal
Deals on Carrywatch
Every deal that names Beijing Continent Pharmaceuticals Co., Ltd, and its role in each.
Catalyst / Beijing Continent Pharmaceuticals Co., Ltd
Catalyst takes controlling interest in Beijing Continent Pharmaceuticals, Co., Ltd.
See deal detailsDeal Web
Beijing Continent Pharmaceuticals Co., Ltd and 0 firms it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Exhibit 99.1 — Beijing Continent Pharmaceuticals Co., Ltd. Condensed Consolidated Financial Statements
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Beijing Continent Pharmaceuticals Co., Ltd:
- P01